Suppr超能文献

一名肝硬化患者的结核病:治疗难题

Tuberculosis in a Liver Cirrhosis Patient: A Management Conundrum.

作者信息

Diggikar Pradnya M, Reddy Hansini R, Mundada Mayank, Pancholi Tushar, Faruqi Ahsan A

机构信息

General Medicine, Dr. D. Y. Patil Medical College, Hospital & Research Centre, Pune, IND.

出版信息

Cureus. 2024 Feb 4;16(2):e53533. doi: 10.7759/cureus.53533. eCollection 2024 Feb.

Abstract

This case report delves into the intricate challenges of managing tuberculosis (TB) in a 70-year-old male with decompensated chronic liver disease (DCLD) and a history of endoscopic variceal ligation. The patient, initially presenting with symptoms such as black-colored stools, breathlessness, and weight loss, was diagnosed with right-sided pneumonia alongside DCLD. Despite the administration of standard beta-lactam plus macrolide antibiotics, the patient exhibited no improvement. Subsequent bronchoscopy revealed (MTB), prompting the initiation of first-line anti-tubercular therapy. However, the hepatotoxic response necessitated a switch to a modified regimen with non-hepatotoxic drugs, emphasizing the challenge of managing TB in cirrhotic patients. Effective management of MTB infection involves personalized administration of anti-TB drugs, taking into account the individual's chronic liver disease status. This case underscores the importance of treating tuberculosis in liver cirrhosis patients based on the Child-Turcotte-Pugh score. A tailored and vigilant approach is indispensable for the successful management of MTB infection.

摘要

本病例报告深入探讨了一名70岁男性患者的复杂治疗挑战,该患者患有失代偿性慢性肝病(DCLD)且有内镜下静脉曲张结扎病史,同时感染了结核病(TB)。患者最初出现黑便、呼吸急促和体重减轻等症状,被诊断为右侧肺炎合并DCLD。尽管使用了标准的β-内酰胺类加大环内酯类抗生素,患者病情并无改善。随后的支气管镜检查发现了结核分枝杆菌(MTB),于是开始进行一线抗结核治疗。然而,由于肝毒性反应,不得不改用非肝毒性药物的改良方案,这凸显了在肝硬化患者中管理结核病的挑战。有效管理MTB感染需要根据个体的慢性肝病状况个性化给药抗结核药物。本病例强调了根据Child-Turcotte-Pugh评分治疗肝硬化患者结核病的重要性。对于成功管理MTB感染,量身定制且警惕的方法必不可少。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ec3/10912889/4a30d35ecdbb/cureus-0016-00000053533-i01.jpg

相似文献

1
Tuberculosis in a Liver Cirrhosis Patient: A Management Conundrum.
Cureus. 2024 Feb 4;16(2):e53533. doi: 10.7759/cureus.53533. eCollection 2024 Feb.
2
Tuberculosis in Cirrhosis - A Diagnostic and Management Conundrum.
J Clin Exp Hepatol. 2022 Mar-Apr;12(2):278-286. doi: 10.1016/j.jceh.2021.09.003. Epub 2021 Sep 10.
3
Clinical and biochemical profile of tuberculosis in patients with liver cirrhosis.
J Clin Exp Hepatol. 2015 Mar;5(1):8-13. doi: 10.1016/j.jceh.2015.01.003. Epub 2015 Jan 27.
4
Antituberculosis drug-induced liver injury in chronic hepatitis and cirrhosis.
J Infect. 2010 Oct;61(4):323-9. doi: 10.1016/j.jinf.2010.07.009. Epub 2010 Jul 27.
5
A guide to the management of tuberculosis in patients with chronic liver disease.
J Clin Exp Hepatol. 2012 Sep;2(3):260-70. doi: 10.1016/j.jceh.2012.07.007. Epub 2012 Sep 21.
6
Anti-tuberculosis drug-induced liver injury in patient with hepatitis B and cirrhosis: A case report.
Ann Med Surg (Lond). 2022 Jul 12;80:104154. doi: 10.1016/j.amsu.2022.104154. eCollection 2022 Aug.
8
Time of Liver Function Abnormal Identification on Prediction of the Risk of Anti-tuberculosis-induced Liver Injury.
J Clin Transl Hepatol. 2023 Apr 28;11(2):425-432. doi: 10.14218/JCTH.2022.00077. Epub 2022 May 20.
9
Predicting antitubercular drug-induced liver injury and its outcome and introducing a novel scoring system.
Int J Mycobacteriol. 2021 Apr-Jun;10(2):116-121. doi: 10.4103/ijmy.ijmy_15_21.
10
Antitubercular therapy induced liver function tests abnormalities in human immunodeficiency virus infected individuals.
Med J Armed Forces India. 2017 Jan;73(1):12-17. doi: 10.1016/j.mjafi.2016.12.003. Epub 2017 Jan 7.

本文引用的文献

1
Global epidemiology of cirrhosis - aetiology, trends and predictions.
Nat Rev Gastroenterol Hepatol. 2023 Jun;20(6):388-398. doi: 10.1038/s41575-023-00759-2. Epub 2023 Mar 28.
2
Reducing global tuberculosis deaths-time for India to step up.
Lancet. 2017 Mar 25;389(10075):1174-1176. doi: 10.1016/S0140-6736(17)30790-0.
3
Hepatotoxicity Related to Anti-tuberculosis Drugs: Mechanisms and Management.
J Clin Exp Hepatol. 2013 Mar;3(1):37-49. doi: 10.1016/j.jceh.2012.12.001. Epub 2012 Dec 20.
4
A guide to the management of tuberculosis in patients with chronic liver disease.
J Clin Exp Hepatol. 2012 Sep;2(3):260-70. doi: 10.1016/j.jceh.2012.07.007. Epub 2012 Sep 21.
5
Prevalence of tuberculosis in patients with cirrhosis of liver in western India.
Trop Doct. 2010 Jul;40(3):163-4. doi: 10.1258/td.2010.090463. Epub 2010 May 17.
6
Ammonia impairs neutrophil phagocytic function in liver disease.
Hepatology. 2008 Oct;48(4):1202-12. doi: 10.1002/hep.22474.
7
Tuberculosis: 6. Extrapulmonary disease.
CMAJ. 1999 Jun 1;160(11):1597-603.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验